Belite Bio logo
VerifiedBiotechnology Research· Founded 2018

Belite Bio

Belite Bio (NASDAQ: BLTE) is a San Diego based clinical stage drug development company targeting untreatable eye diseases, such as dry AMD and Stargardt disease (STGD1) which is the most common inherited retinal dystrophy, and metabolic diseases. Its lead pipeline, Tinlarebant (aka LBS-008), is a novel oral once-a-day tablet intended to treat Dry AMD and STGD1 early. Tinlarebant is in phase 3 and has been granted Fast Track & RPD designation in the US, and ODD in the US and EMA for STGD1.

7-day free trial · no credit card

HeadquartersSan Diego, United StatesEmployees34(11 to 50)Founded year2018Websitebelitebio.comLinkedIn profileLinkedIn

Verified contacts

23

available on Kipplo

LinkedIn employees

34

11 to 50 range

Open roles

no listings

Distinct roles

20

indexed titles

Tech stack

1

tools in use

Monthly traffic

organic / mo

Sign up free to see all 23 verified contacts at Belite Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Decision-makers and verified team members

23 contacts with verified email or phone · masked until revealed.

Sign up free →

Top roles at Belite Bio

20 distinct titles indexed · top 10 shown.

  • 2clinical project manager
  • 2spark therapeutics, inc
  • 1, -
  • 1associate director
  • 1chairman and ceo
  • 1clinical finance associate
  • 1clinical trial associate
  • 1clinical trial project manager
  • 1finance manager
  • 1independent director
  • +10more titles

Sign up to unlock all 23 contacts at Belite Bio

Free for 7 days · 50 credits · no card · only pay for verified records.

Sign up free

Sign up to reveal 23 verified contacts at Belite Bio

7-day trial · no credit card · cancel anytime · only pay for verified records.

Trusted by sales, marketing, and GTM engineering teams.

Belite Bio | Kipplo Discover